Major clinical trial–related policy changes at the U.S. Department of Health and Human Services (HHS) are leading to ambiguity for sites, sponsors, and contract research organizations. Questions remain on how clinical research professionals can best operationalize these changes, align processes, and address compliance challenges.
As experienced pharmaceutical industry executive Mo Ali settled into his volunteer duties as Chair of the ACRP Board of Trustees for 2026, a year in which the Association celebrates its 50th anniversary of service to its members and stakeholders, he took time to answer some questions about his experience in the clinical research enterprise, some of the challenges and opportunities facing it, and how ACRP can further its mission in a time of rapidly evolving technologies and processes.
The Health Care Compliance Association’s 30th Annual Compliance Institute (CI), taking place April 27–30, 2026, in Orlando or virtually, offers practical tools and insights to support this work.
Jerry Stein, PhD, ACRP-CP, ACRP-MD, FACRP, shares his pride in contributing to ACRP’s legacy of providing educational offerings, networking, and other services to meet the needs of members who are both independent clinical researchers and small business owners.
Strong leadership is the backbone of strong companies. The “four Cs” framework for leadership (character, competence, caring, and communication) can be adapted to a wide range of cultures, regulatory demands, and operational needs.